chr15-51893842-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_014547.5(TMOD3):c.524C>T(p.Pro175Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000747 in 1,606,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000074 ( 0 hom. )
Consequence
TMOD3
NM_014547.5 missense
NM_014547.5 missense
Scores
4
11
4
Clinical Significance
Conservation
PhyloP100: 7.18
Genes affected
TMOD3 (HGNC:11873): (tropomodulin 3) Enables cadherin binding activity involved in cell-cell adhesion. Predicted to be involved in actin filament organization; muscle contraction; and myofibril assembly. Predicted to act upstream of or within actin cytoskeleton organization; erythrocyte development; and positive regulation of mitotic cell cycle phase transition. Located in adherens junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.859
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMOD3 | NM_014547.5 | c.524C>T | p.Pro175Leu | missense_variant | 6/10 | ENST00000308580.12 | NP_055362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMOD3 | ENST00000308580.12 | c.524C>T | p.Pro175Leu | missense_variant | 6/10 | 1 | NM_014547.5 | ENSP00000308753 | P1 | |
TMOD3 | ENST00000560549.5 | c.107C>T | p.Pro36Leu | missense_variant, NMD_transcript_variant | 4/12 | 1 | ENSP00000454040 | |||
ENST00000558142.1 | n.229-1364G>A | intron_variant, non_coding_transcript_variant | 3 | |||||||
TMOD3 | ENST00000561438.5 | c.29C>T | p.Pro10Leu | missense_variant, NMD_transcript_variant | 1/8 | 5 | ENSP00000452939 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152072Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
152072
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000442 AC: 11AN: 249068Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134722
GnomAD3 exomes
AF:
AC:
11
AN:
249068
Hom.:
AF XY:
AC XY:
5
AN XY:
134722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000743 AC: 108AN: 1454150Hom.: 0 Cov.: 33 AF XY: 0.0000720 AC XY: 52AN XY: 722684
GnomAD4 exome
AF:
AC:
108
AN:
1454150
Hom.:
Cov.:
33
AF XY:
AC XY:
52
AN XY:
722684
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152072Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74274
GnomAD4 genome
AF:
AC:
12
AN:
152072
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.524C>T (p.P175L) alteration is located in exon 6 (coding exon 5) of the TMOD3 gene. This alteration results from a C to T substitution at nucleotide position 524, causing the proline (P) at amino acid position 175 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Pathogenic
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at